PRLD vs RL · rev $6.5M vs P/E 24, rev $8.11B
Prelude Therapeutics Inc (PRLD) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
PRLD currently screens at market cap $346.5M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the PRLD and RL stock pages for the full models.
Not investment advice.